US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
HCW Biologics Inc (HCWB)
HCW Biologics Inc (HCWB) ニュース

HCWB

HCW Biologics (HCWB)

HCW Biologics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:HCWB

1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/21	05 : 36	Edgar (US Regulatory)	Form ARS/A - Annual Report to Security Holders: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
2024/05/16	06 : 21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HCWB	HCW Biologics Inc
2024/05/16	05 : 45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
2024/05/16	05 : 39	GlobeNewswire Inc.	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
2024/05/16	05 : 35	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NASDAQ:HCWB	HCW Biologics Inc
2024/04/02	05 : 10	GlobeNewswire Inc.	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
2024/02/28	06 : 27	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:HCWB	HCW Biologics Inc
2024/02/23	04 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2024/02/23	04 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2024/02/23	04 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2024/02/23	04 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2024/02/22	22 : 39	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
2024/01/12	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
2023/12/12	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/12/12	06 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/11/21	06 : 55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/11/14	21 : 00	GlobeNewswire Inc.	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights	NASDAQ:HCWB	HCW Biologics Inc
2023/11/08	21 : 30	GlobeNewswire Inc.	Investigator Sponsor of HCW Biologics’ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
2023/11/01	20 : 30	GlobeNewswire Inc.	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting	NASDAQ:HCWB	HCW Biologics Inc
2023/10/24	05 : 44	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/19	05 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/16	07 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/14	06 : 33	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/09	06 : 25	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/08	05 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HCWB	HCW Biologics Inc
2023/09/06	20 : 30	GlobeNewswire Inc.	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023	NASDAQ:HCWB	HCW Biologics Inc
2023/08/31	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
2023/08/24	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc
2023/08/11	20 : 31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HCWB	HCW Biologics Inc
2023/08/11	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HCWB	HCW Biologics Inc

Showing the most relevant articles for your search:NASDAQ:HCWB

1 2 3 4 5 次へ >>

Hasselt HASSE3.204%29NOV23

Morgan Stanley Bank Na A...

Amundi MSCI World Financ...

Jpm Us Rei Dist

Nederlandsche Apparatenf... (PK)

Vontobel Financial Produ...

Gs Finance Corp Point to...

Open Exchange Token

New Zealand Oil and Gas (PK)

Rockwealth Resources

Mill City Ventures III (QB)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約